Endometriosis Trial, Recruiting NCT06660043 Sponsor: Fondation Hôpital Saint-Joseph Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06660043
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman aged 18 to 55 who still has regular periods
  • You have a confirmed diagnosis of endometriosis, shown by a pelvic ultrasound or MRI scan
  • You experience endometriosis-related pain rated above 3 out of 10, and/or have ongoing symptoms from endometriosis that seriously affect your daily life
  • You are either not currently on any treatment for endometriosis, or you have been on a stable treatment (such as the pill and/or a hormonal medication) that has not changed in the last 6 months
  • You are covered by a health insurance scheme
  • You speak French
  • You are willing to give your verbal agreement to take part after being fully informed about the trial

Who may not be able to join:

  • Your endometriosis treatment has been changed or started within the last 6 months
  • Your endometriosis-related pain is rated 8 out of 10 or higher
  • You have heart or cardiovascular health concerns that make physical exercise risky for you
  • You are physically unable to perform the exercises proposed in the trial
  • You are under legal guardianship
  • You are currently deprived of your liberty (for example, in custody or detention)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Frederique PERROTTE, Fondation Hôpital Saint-Joseph

Phone: +33144127963

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondation Hôpital Saint-Joseph
Registry
ClinicalTrials.gov
Start date
21 March 2024
Est. completion
20 March 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Evaluation of quality of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov